True North Cannabis Corp. has licensed highly innovative proprietary liposome encapsulated technology from Panag Pharma, a subsidiary of Tetra Bio-Pharma, who will collect royalties on sales on products distributed under the True North brand that are produced with the tech.
Tetra’s patented technology leads to better absorption and aqueous emulsification of the CBD molecule in a variety of products. Panag will work with True North’s product team to integrate this technology and develop a line of hemp-derived CBD formulations for True North and its partners to commercialize through its existing distribution relationships in both the medical and recreational markets in Canada.
In developing these products, the Panag team is using Tetra’s liposome encapsulated technology, a patented process to encapsulate and protect the active molecules into a multi-layered sphere. Delivery of the formulation is greatly improved by enhancing the dispersion of loaded liposomal spheres within an aqueous (water-based) environment.
“This opportunity is the beginning of a great relationship between the two companies. Panag has enjoyed working closely with the True North team and we are very excited at the expansion of our pipeline with innovative wellness products that fit within their portfolio, in the competitive and growing CBD market,” said Chris MacLean, chief operating officer of Panag Pharma.
“I am glad that this highly innovative and patented technology will benefit the wellness market. We are adapting our pharmaceutical technologies for the benefit of True North customers,” said Steeve Néron, chief commercial officer of Tetra BioPharma.
“True North is pleased to have entered into a licensing agreement with Panag Pharma to exclusively incorporate their molecular technology into product formulations distributed under the True North brand. Panag’s patented CBD encapsulation technology is expected to further differentiate True North’s branded product offering in the highly competitive medical and recreational CBD product market. True North looks forward to bringing an exciting array of innovative products utilizing this technology to consumers across the country,” said Brett Halvorson, president and chief financial officer of True North.
True North Cannabis Corp. is a Canadian hemp-based CBD products company. True North and its partners supply value-priced CBD bulk ingredients to licensed producers across Canada, and deliver a range of extracted and edible CBD products to patients and consumers alike through the True North brand.
Tetra Bio-Pharma is involved in cannabinoid-derived drug discovery and development with an FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Their evidence-based scientific approach has enabled them to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation and oncology.
